Company / Capital Expenditures
Warby Parker Inc. Capital Expenditures History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$67.0M
FY2025
5-year range
$20.1M / $67.0M
FY2021-FY2025
Trend
+4.7%
vs FY2024
Sector context
#73 of 151
Health Care
What the data says
At $67M, Warby Parker Inc.'s capital expenditures ranks #73 of 151 in the Health Care sector. Capital Expenditures has increased for 3 consecutive years, from $20M in FY2022 to $67M in FY2025.
Based on SEC 10-K filings.
$67M in FY2025 with a 5-year CAGR of +27.3%.
Improved from $54M to $67M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +49.5%
- 5-Year CAGR
- +27.3%
- 10-Year CAGR
- -
Sector benchmark
#73 of 151 in Health CareTop 48% of 151This company $67.0M Sector average $271.7M
▼
-75.3% below sector average
Key checks
Key Insights
- Warby Parker Inc.'s capital expenditures has grown for 3 consecutive years.
- 5-year CAGR of +27.3%, indicating consistent growth.
- In FY2025, capital expenditures increased 4.7% year-over-year.
- Ranks #73 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $67.0M | +4.7% |
| FY2024 | $64.0M | +19.3% |
| FY2023 | $53.7M | +167.4% |
| FY2022 | $20.1M | -38.5% |
| FY2021 | $32.6M | +62.6% |
| FY2020 | $20.1M | -38.5% |
| FY2019 | $32.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026